• Bulletin of the Korean Chemical Society
• /
• 제33권8호
• /
• pp.2613-2618
• /
• 2012

Hydrothermal route have been used in different conditions for preparation of $Ni(OH)_2$ nanostructures. The NiO nanoparticles were obtained by calcining the $Ni(OH)_2$ precursor at $450^{\circ}C$ for 2 h. The effect of sodium dodecyl sulfonate (SDS) as surfactant on the morphology and size of $Ni(OH)_2$ nanoparticles were discussed in detail. X-ray diffraction (XRD), Scanning electron microscopy (SEM), Transmission electron microscopy (TEM) and Fourier transform infrared (FT-IR) spectroscopy were used to characterize the products. The growth mechanism of the as-synthesized nanostructures was also discussed in detail based on the experimental results. Coming up, the NiO nanoparticle modified carbon paste electrode was applied to the determination of captopril in aqueous solution.

• Journal of Chest Surgery
• /
• 제20권1호
• /
• pp.171-176
• /
• 1987

Takayasu`s arteritis is one of chronic inflammatory disease characteristically involving the aorta and its major branches. Symptoms and signs of the disease are various depending on the involved area. We experienced a surgical case of Takayasu`s arteritis mainly involving both renal arteries with renovascular hypertension in a 13 year old girl. Hypertension was not controlled by medical treatment including diuretics and captopril [160/140 mmHg]. Aortogram showed severely stenosed right renal artery, nearly obstructed left renal artery and not visulalized superior mesenteric artery. Angioplasty was performed for the right renal artery but aorta-renal bypass graft with greater saphenous vein was inevitable for the left renal artery. Blood pressure was controlled sufficiently with some adjunct of captopril postoperatively [130/90 mmHg]. While the patient was discharged with much improvement, she was lost follow up and died of not identified definitive cause 3 months later.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 1996년도 춘계학술대회
• /
• pp.248-248
• /
• 1996

경구투여급성독성시험 : 암수동물의 모든 투여군에서 시험물질투여에 의한 일반증상, 체중변화 및 육안적 부검소견은 관찰되지 않았으며. 따라서 반수치사량(LD$_{50}$)은 암수동물의 경우 5000mg/kg이상이었다. 경구투여아급성독성시험 : SD랫트의 암수 동물에 있어서 Captopril(SR Tablet 25mg)의 2000mg/kg 용량은 확실중독량에 해당되며, 무영향량(NOEL)은 220mg/kg용량이라고 사료되었다.

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 1989년도 제28차 춘계학술대회
• /
• pp.135.2-136
• /
• 1989

• 대한약학회:학술대회논문집
• /
• 대한약학회 2000년도 춘계총회 및 학술대회
• /
• pp.203.1-203.1
• /
• 2000

• 대한한방내과학회지
• /
• 제31권3호
• /
• pp.600-611
• /
• 2010

Purpose : This study was to observe the nephroprotective effects of the traditional prescription, Opi-san(OPS). OPS has been generally used for treating various edematous renal diseases, including acute renal failure. Methods : Three different dosages of OPS extracts were administered once a day for 28 days (5 mg/kg, single intraperitoneally administered). On the 23rd day after OPS extract treatment, cisplatin was treated. All the rats (6 groups of 8 rats each) were checked as follows. Changes of body weight, kidney weight, serum BUN and creatinine levels were observed, as well as changes to the kidney MDA and GSH contents. The results were compared with captopril 100 mg/kg, of which the effects on cisplatin-induced acute renal failures were already confirmed. Results : Cisplatin-induced ARF were induced by oxidative stress and related lipid peroxidation in the present study. However, these ARF and inhibition of antioxidant effects induced by cisplatin were dose-dependently reduced by treatment of OPS extracts except in the 100 mg/kg treated group. The effects of OPS extracts at 500 mg/kg were similar to those of 100 mg/kg of captopril. Conclusion : This study suggests that OPS extracts 500 mg/kg showed favorable effects on the cisplatin-induced rat's ARF as similar to 100 mg/kg of captopril.

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 1988년도 제27차 춘계학술대회
• /
• pp.135.2-136
• /
• 1988

• 대한핵의학회:학술대회논문집
• /
• 대한핵의학회 1987년도 제26차 춘계학술대회
• /
• pp.124.2-125
• /
• 1987

• Asian-Australasian Journal of Animal Sciences
• /
• 제21권5호
• /
• pp.732-737
• /
• 2008

This study developed a natural ingredient as a functional food possessing properties of attenuation of hypertension and cardiovascular hypertrophy. In a previous study hydrolysates obtained from chicken leg bone protein using Alcalase strongly inhibited angiotensin I converting enzyme (ACE) in vitro. In particular, hydrolysate (A4H) from four hours of incubation exhibited the highest ACE inhibitory activity (IC50 = 0.545 mg/ml). A4H was selected as a potent ACE inhibitor and orally administrated to spontaneously hypertensive rats (SHR) for eight weeks to investigate attenuating effects on age-related development of hypertension and cardiovascular hypertrophy. Results showed that treatment with A4H of SHRs attenuated the development of hypertension as effectively as the clinical antihypertensive drug captopril. Moreover, a significantly lower heart to body weight ratio and thinness of coronary arterial wall was observed in SHRs that had been treated with A4H or captopril. The results suggest that A4H can be utilized in developing an ACE inhibitor as a potential ingredient of functional foods to alleviate hypertension and cardiovascular hypertrophy.

• Biomolecules & Therapeutics
• /
• 제1권2호
• /
• pp.220-225
• /
• 1993

Effect of BR-900317 on the angiotensin I-induced pressor response in pithed rats and the effects of its single oral administration on plasma angiotensin converting enzyme (ACE) activities in normotensive rats and on the cardiovascular system in hypertensive model rats (SHR, RHR), were compared with those of captopril. BR-900317 attenuated the angiotensin I-induced pressor effects in pithed rats. In a single oral dose administration study, BR-900317 inhibited the plasma ACE activities in a dose-dependent fashion. Duration of the action of BR-900317 was similar to that of captopril. BR-900317 produced antihypertensive effect in spontaneously hypertensive rats and dose-dependent antihypertensive effect in 2-kidney Goldblatt hypertensive rats without affecting heart rate. These results suggest that the main mechanism of the antihypertensive effect of BR-900317 is the suppression of angiotensin II production due to the inhibition of the ACE.